top of page

Search Results

Results found for "Strosberg AD"

  • Why Opposing Processes Matter for Your Next GPCR Drug

    example, signal spontaneously, meaning a neutral antagonist won’t suppress appetite; it just blocks added

  • Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells

    affect receptors’ properties.[10,11] BBVs also lack downstream signaling components, which can be an advantage The reaction was initiated by the addition of 1 μL D3 receptor displaying BBVs (CD3R = 0.7 nM) to 0.5 An equivalent volume of assay buffer was added to association controls (filled dark blue circles). The results suggest that adding the linker to the pharmacophore slows down both association and dissociation HEK293-D3R cells in DMEM medium with added 9% FBS and antibiotic antimycotic solution were incubated

  • From Snapshots to Predictions: Why Mechanism of Action Matters

    You add a non-radioactive analog of a ligand, expecting it to displace binding. With a model, it becomes explainable: if the dimer form has higher affinity, then adding ligand actually Internal checks (like requiring a Schild regression slope of unity for competitive antagonism) add further Action” now Only in Terry’s Corner   Why Terry’s Corner When early choices determine which programs advance Subscriber-driven topics,  so the next lesson addresses your bottleneck.

  • Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls

    Binding affinity appears straightforward: add ligand, measure signal, fit a curve. Complex Two-Stage Biology Behind Orthosteric Binding GPCR pharmacology rarely follows the neat Langmuir adsorption receptor levels also deplete free tracer when tracer concentrations are low, breaking the assumption that added Non-specific binding control:  Adsorption to surfaces changes free ligand concentration. Terry Kenakin give scientists an uncommon advantage: the ability to interrogate foundational assumptions

  • Dr. GPCR University registration is now open! Secure your spot now!

    pharmaceuticals and drug discovery, it is crucial for professionals to stay informed about the latest advancements We have 18 GPCR papers, four industry news articles, and two job ads. Connect with fellow scientists and dive into the latest in adhesion GPCR biology. in GPCR-targeted drug development in dermatology Advances in small-molecule insulin secretagogues for How To Discover Biologics For Challenging Targets Drug discovery, a biophysics perspective Bio-Rad Adds

  • 📰 GPCR Weekly News, April 1 to 7, 2024

    In this edition, we have curated eight GPCR papers, five industry news, and two job ads. Samuel Hoare on Advanced data analysis for GPCR pharmacology, which will be held on Thursdays between Please complete this form to take advantage of this opportunity. Chemoattractant receptor signaling in humoral immunity Industry News Neurosterix launches with $63M to Advance Biologics US 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry October 23 - 25, 2024 | 11th Adhesion

  • Exploring the Breakthroughs in GPCR Research

    We have 15 GPCR papers, three industry news, and two job ads. Principles of Pharmacology in Drug Discovery II - Advanced Methods for the Optimization of Candidate October 3rd to 31st, 2024 Overview: Building on the basics covered in Course I, this course explores advanced GPCR Event Highlight 11th Adhesion GPCR Workshop Hosted by the Adhesion GPCR Consortium, this event will Join fellow scientists and researchers in person to stay updated with adhesion GPCR biology.

  • How Early Strategic Decision Making Creates Alignment and Better Results

    Teams believe they can correct course by adjusting execution. This is not about adding more meetings or creating heavier processes.

  • Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes

    Additionally, GLP-1R couple to G protein-coupled receptor kinases (GRKs) and recruit β-arrestins, adding Moreover, exendin-P5 has been observed to reduce adipose tissue size more effectively than exendin, suggesting Indeed, incretin-based drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound are advancing diabetes Anson, M., et al., Incidence of new onset type 2 diabetes in adults living with obesity treated with Rodriguez, P.J., et al., Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity

  • Why Fundraising Mistakes Kill Strong Biotech Startups

    . 👉 In reality, every fundraising-driven adjustment leaves a structural mark on how the company operates In strong biotech startups, they surface as reasonable adjustments that seem aligned with reality. Roles are added to demonstrate scale, even when the organization is not structurally ready to support As this pattern repeats, the organization adapts. Additional scrutiny is applied exactly where urgency would normally shortcut thinking.

  • 📰 GPCR Weekly News, March 11 to 17, 2024

    We have 10 GPCR papers, five industry news, and one job ad. Let’s dive into the Classified GPCR News from March 11th to 17th, 2024 Adhesion GPCRs ADGRG1, an adhesion by a GPCR Industry News Domain Therapeutics and Chime Biologics announce manufacturing agreement  to advance Breakthrough in 3D Protein Structure Prediction of Large, Complex Protein Structures Newly discovered adhesion Biologics US 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry October 23 - 25, 2024 | 11th Adhesion

  • 📰 GPCR Weekly News, February 5 to 11, 2024

    We have 10 GPCR papers, six industry news, and two job ads. Additionally, if you participated in our Symposia in 2023, please take a moment to fill out this survey FENS Forum 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry October 23 - 25, 2024 | 11th Adhesion

  • 📰 GPCR Weekly News, April 22 to 28, 2024

    We have 15 GPCR papers, two industry news, and one job ad. congrats to: AndrÊ Nguyen Dietzsch, Simone PrÜmel, et al. for their work on the Dysfunction of the adhesion GPCR latrophilin 1 (ADGRL1/LPHN1) increases the risk of obesity Norton Cheng, JoAnn Trejo, et al. for Please complete this form to take advantage of this opportunity on a first-come, first-served basis. the adhesion G protein-coupled receptor latrophilin 1 (ADGRL1/LPHN1) increases the risk of obesity GPCR

  • 📰 GPCR Weekly News, April 15 to 21, 2024

    Additionally, we have six industry news. And if you're looking for a new job opportunity, we have one job ad. Please complete this form to take advantage of this opportunity on a first-come, first-served basis. Samuel Hoare on Advanced data analysis for GPCR pharmacology, which will be held on Thursdays between more Deorphanization of G Protein Coupled Receptors (GPCRs): a historical perspective Industry News Addex

  • 📰 GPCR Weekly News, January 8 to 14, 2024

    We’ve curated 10 GPCR papers, seven industry news, and two GPCR job ads! This week's highlight: Dr. Kathleen M Caron and her team studied the GPER/GPR30 complex with β1-adrenergic receptor and AKAP5 in Let’s dive into the Classified GPCR News from January 8th to 14th, 2024 Adhesion GPCRs Conformational transitions and activation of the adhesion receptor CD97 GPCR Activation and Signaling Biased Signaling in Mutated Variants of β2-Adrenergic Receptor: Insights from Molecular Dynamics Simulations GPCRs in

  • 📰 GPCR Weekly News, February 12 to 18, 2024

    our comprehensive GPCR coverage for the week; we have 14 GPCR papers, six industry news, and two job ads Additionally, if you participated in our Symposia in 2023, please take a moment to fill out this survey FENS Forum 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry October 23 - 25, 2024 | 11th Adhesion

  • 📰 GPCR Weekly News, April 8 to 14, 2024

    We have 15 GPCR papers, three industry news, one event, and one job ad. Samuel Hoare on Advanced data analysis for GPCR pharmacology, which will be held on Thursdays between Please complete this form to take advantage of this opportunity. Let’s dive into the Classified GPCR News from April 8th to 14th, 2024 Adhesion GPCRs High incidence of imperforate vagina in ADGRA3-deficient mice GPCR Activation and Signaling Local anesthetics inhibit

  • 📰 GPCR Weekly News, January 15 to 21, 2024

    for this week, which includes 14 GPCR papers, four industry news, one GPCR Event, and two GPCR job ads Graham Ladds’ team refines AlphaFold models using binding calculations for human adenosine A3 receptor Due to popular demand, we have opened additional spots. If you'd like to join colleagues and Dr. Let’s dive into the Classified GPCR News from January 15th to 21st, 2024 Adhesion GPCRs The adhesion GPCR GPR116/ADGRF5 has a dual function in pancreatic islets regulating somatostatin release and islet

  • 📰 GPCR Weekly News, February 19 to 25, 2024

    We have 19 GPCR papers, six industry news, two events, and two job ads. Additionally, we will be conducting a poster session in Zoom breakout rooms. Let’s dive into the Classified GPCR News from  February 19th to 25th, 2024 Adhesion GPCRs The Adhesion coupled receptor promotes the restoration of tension in epithelial cells GPCR Binders, Drugs, and more Advances Biologics US 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry October 23 - 25, 2024 | 11th Adhesion

  • 📰 GPCR Weekly News, January 29 to February 4, 2024

    We have 21 GPCR papers, three industry news, and two job ads. Additionally, if you participated in our Symposia in 2023, please take a moment to fill out this survey Let’s dive into the Classified GPCR News from January 29th to February 4th, 2024 Adhesion GPCRs CELSR1 , a core planar cell polarity protein, features a weakly adhesive and flexible cadherin ectodomain GPCR toxin B and FZD7 Loss-of-function of GNAL dystonia gene impairs striatal dopamine receptors-mediated adenylyl

  • Glyco-sulfo hotspots in the chemokine receptor system

    Tyrosine sulfation consists in the transfer of a sulfate group from the adenosine 3’-phosphate 5’-phosphosulfate Sulfo-glyco barcode - perspectives and added value in drug discovery A growing body of evidence proposes In addition, tyrosine sulfation is heterogenous between cell lines or even on the same cell (Scurci I

  • The Perils and Guardrails of Modifying Signalling Proteins in Bioassays

    This pursuit in the best cases has remarkably led to groundbreaking technological advancements, such The authors emphasise the importance of understanding the advantages and limitations of different assay Advancements in G protein-coupled receptor biosensors to study GPCR-G protein coupling. Rößler P, Mayer D, Tsai CJ, Veprintsev DB, Schertler GFX, Gossert AD. Science advances. 2022;8(23):eabo4158. 53.         Carroll S.

  • Four Reasons to Measure GPCR Signaling Bias in Drug Discovery

    for signaling bias often fail to fully understand the distinction and risk candidate molecules from advancing receptor have been explored as a strategy to preserve analgesia, while reducing β-arrestin-dependent adverse The β2-adrenoceptor bronchodilator clenbuterol, for example, exhibits 500-fold selectivity for β2 over powerful applications of GPCR biased signaling is the ability to separate therapeutic effects from adverse Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G protein and arrestin coupling

  • When the Assay Says Nothing, Look Again: Kinetic Detection of Multi-Target GPCR Activity

    how two pharmacophores are encoded into one scaffold, and why a uniform PK profile changes what co-administration The two-edged character of multi-target engagement: why therapeutic breadth and side effect liability advance sequence carries a region responsible for efficacy and a separate region that functions as a binding address

  • Unlocking the Therapeutic Potential of Previously Undruggable GPCRs

    Spurred on by new scientific and technological advances related to the understanding of structure and The engineered analog approach involves optimizing this scaffold, adding and subtracting molecular contacts Orion’s approach to engineering ligand analogs involves leaving the ‘address’ binding interface on the This characteristic provides a major advantage in drug discovery: massive parallel library-based screening Sci Adv, 7. https://doi.org/10.1126/sciadv.abg8685 · Structural explanation of the binding and

  • GPCR Drug Discovery Summit 2026: What to Expect in Boston — and How to Register

    Drug Discovery Summit 2026 The meeting brings together 80+ senior leaders from biotech and pharma to advance more presentations on non-small molecule approaches — including agonistic antibodies, GPCR-directed ADCs

  • GPCR Happy Hour Boston 2026 — April 29 | Dr. GPCR Community Event

    Montana Molecular Montana Molecular is a leader in advanced GPCR assay technologies and services, combining

  • Beyond HEK293 — Terry HĂŠbert on iPSC-Derived GPCR Models, Live April 16,

    Thursday, April 16, 1:00 PM ET  — note the adjusted time. Advanced quantitative approaches to understanding how ligands produce biased signaling — and what that

  • GPCR Selectivity Beyond the Receptor — Live April 9th with Bryan Roth

    Thursday, April 16, 1:00 PM ET  — note the adjusted time. Binder2030 addresses this gap — a curated affinity selection-mass spectrometry dataset comprising 3,384 biologics, irreversible inhibitors, and molecular glues — and how these unconventional ligand classes address

  • Understanding Biased Signaling in GPCRs

    This Masterclass with Bryan Roth will examine an additional mechanism: intracellular modulators that

bottom of page